Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies

Richard R. Rubin, Mark Peyrot

    Research output: Contribution to journalArticle

    Original languageEnglish (US)
    Pages (from-to)2495-2497
    Number of pages3
    JournalDiabetes care
    Volume27
    Issue number10
    DOIs
    StatePublished - Oct 1 2004

    ASJC Scopus subject areas

    • Internal Medicine
    • Endocrinology, Diabetes and Metabolism
    • Advanced and Specialized Nursing

    Cite this